Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩39.66T | 196.3x | -2.78 | ₩192,500 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.9% Upside | Upgrade to Pro+ | |
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.52T | -1,276.9x | -14.15 | ₩93,500 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩2.02T | -108.9x | 15.87 | ₩94,100 | -3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.83T | ₩23,300 | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||||
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.32T | -29.4x | 0.06 | ₩26,400 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.27T | -35.3x | 5.04 | ₩68,300 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.08T | 36.5x | 0.03 | ₩23,450 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomictree | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩563.77B | -42.3x | -13.43 | ₩23,050 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioneer | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩503.3B | -19.4x | 0.03 | ₩19,030 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medipost | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩408.16B | -42.6x | 0.06 | ₩12,350 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SillaJen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩352.15B | -10.9x | 1.56 | ₩2,420 | -5.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AprilBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩349.32B | ₩15,060 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ToolGen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩340.55B | -6.8x | 0.04 | ₩38,500 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩319.77B | -13.2x | 0.81 | ₩16,490 | -11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genexine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩252.87B | -4.3x | -0.09 | ₩5,320 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellivery | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩248.38B | -0.44 | ₩6,680 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Vaxcell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩240.05B | -25x | -27.82 | ₩10,000 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmAbcine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩233.76B | -0.45 | ₩2,915 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Amicogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩215.7B | -5.1x | -0.77 | ₩3,605 | -8.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bridge Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩204.67B | -3.2x | -0.2 | ₩3,940 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nibec | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩184.64B | ₩16,210 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Abion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩180.61B | -3.9x | 0.1 | ₩6,950 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
iNtRON Biotechnology | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩178.65B | -40.2x | -0.81 | ₩5,390 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Corestem | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩176.37B | -7.8x | 0.04 | ₩5,070 | -30% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AptaBio Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩172.85B | -7.5x | 0.17 | ₩6,160 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NKMAX | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩172.74B | 31.1x | 0.07 | ₩2,020 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB BioStep | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩171.76B | -35.1x | 0.15 | ₩2,005 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Macrogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩165.15B | -7.7x | -3.23 | ₩16,420 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GeneOne Life Science | Seoul | Healthcare | Biotechnology & Medical Research | ₩162.05B | -2.3x | 0.07 | ₩1,995 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medpacto | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩153.13B | -6x | -0.16 | ₩4,425 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |